Related references
Note: Only part of the references are listed.Hepatic Arterial Infusion of Oxaliplatin Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
Qi-Jiong Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
Bernhard Scheiner et al.
JOURNAL OF HEPATOLOGY (2022)
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
Takeshi Hatanaka et al.
HEPATOLOGY INTERNATIONAL (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial
MinKe He et al.
JAMA ONCOLOGY (2019)
Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study
Xubiao Wei et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma
Ning Lyu et al.
GUT (2018)
Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis
Min-Ke He et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized
Min-Ke He et al.
CHINESE JOURNAL OF CANCER (2017)
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
Takashi Kokudo et al.
JOURNAL OF HEPATOLOGY (2016)
Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy
Shozo Mori et al.
AMERICAN JOURNAL OF SURGERY (2015)
Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of Response Evaluation Criteria in Solid Tumors and tumor markers
Daisuke Miyaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa et al.
BMC GASTROENTEROLOGY (2014)
How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
Florian Hucke et al.
JOURNAL OF HEPATOLOGY (2014)
A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Masafumi Ikeda et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma
Wolfgang Sieghart et al.
HEPATOLOGY (2013)
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression
Khairuddin Memon et al.
JOURNAL OF HEPATOLOGY (2013)
Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib
Sabrina Kermiche-Rahali et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
Jun Luo et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Complete regression induced by sorafenib of locally advanced HCC allowing curative resection
Sabine Irtan et al.
LIVER INTERNATIONAL (2011)
Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma
Tatsuya Yamashita et al.
ONCOLOGY (2011)
Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival
Goh Eun Chung et al.
RADIOLOGY (2011)
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
Riad Salem et al.
GASTROENTEROLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Ryul Eun et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and efficacy of Y-90 radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M. Kulik et al.
HEPATOLOGY (2008)
Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma
Ryo Toya et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Human C-reactive protein binds activating Fcγ receptors and protects myeloma tumor cells from apoptosis
Jing Yang et al.
CANCER CELL (2007)
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model
R Dzodic et al.
ANTI-CANCER DRUGS (2004)
Hepatocellular carcinoma in Central Europe: prognostic features and survival
M Schoniger-Hekele et al.
GUT (2001)
Share Paper
